BELE INVEST ApS: Financial statements 2013
CVR: 20275499
Source: annual report 2013, Danish Business Authority
01/07/2012 – 30/06/2013
BELE INVEST ApS (CVR 20275499) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -1,243,194 and a net result of DKK -1,032,949. Equity in the 2013 report amounted to DKK -847,848.
- Gross Profit
- DKK -1,243,194
- Profit/Loss
- DKK -1,032,949
- Equity
- DKK -847,848
- Total Assets
- DKK 1,270,623
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of May 15, 2013, Jens Aabye Dam is registered as direktion of BELE INVEST ApS.
As of May 15, 2013, Dina Asmussen has stepped down as direktion of BELE INVEST ApS.
As of April 23, 2013, Dina Asmussen is registered as direktion of BELE INVEST ApS.
As of April 23, 2013, Bo Flemming Voergaard has stepped down as adm. dir of BELE INVEST ApS.
As of February 18, 2013, Bo Flemming Voergaard is registered as adm. dir of BELE INVEST ApS.
As of February 18, 2013, Kaj Erik Larsen has stepped down as adm. dir of BELE INVEST ApS.
About BELE INVEST ApS
BELE INVEST ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 1997. The company has been dissolved on 26 July 2017. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named T-CELLIC A/S and TORSANA ONCOLOGY SYSTEMS A/S. The company has 15 employees (2005). In 2015, the company reported a gross profit of DKK 4,781 and a net result of DKK -163,046 compared with DKK -1,579,251 the year before. Equity in the 2015 report amounted to DKK 59,854.